Show simple item record

dc.contributor.authorKobak, Senol
dc.contributor.authorGungen, Adil Can
dc.contributor.authorDogan Gungen, Belma
dc.contributor.authorTutpinar, Yildiray
dc.contributor.authorGuler, Mehtap
dc.date.accessioned2020-09-10T13:27:31Z
dc.date.available2020-09-10T13:27:31Z
dc.date.issued2020
dc.identifier.citationKobak, S., Gungen, A. C., Gungen, B. D., Tutpinar, Y., & Guler, M. (2020). Secukinumab in a patient with sarcoidosis. Scandinavian Journal of Rheumatology, 1-2.en_US
dc.identifier.issn0300-9742
dc.identifier.urihttps://doi.org/10.1080/03009742.2020.1784460
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1010
dc.descriptionPubmed: 32870066en_US
dc.description.abstractSarcoidosis is a systemic granulomatous disease, characterized by non-caseating granuloma formation. It usually involves the lungs, but may also affect the eyes, heart, skin, and musculoskeletal system. The pathogenesis is not well known, but it is generally accepted as Th1 disease. The role of Th17-induced cytokines in the development of sarcoid granuloma has been reported.en_US
dc.language.isoengen_US
dc.publisherTaylor and Francis Ltden_US
dc.relation.isversionof10.1080/03009742.2020.1784460en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSecukinumab in a patient with sarcoidosisen_US
dc.typeletteren_US
dc.contributor.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.authorID0000-0001-8270-640Xen_US
dc.contributor.authorID0000-0002-2676-723Xen_US
dc.contributor.institutionauthorKobak, Senol
dc.contributor.institutionauthorGungen, Adil Can
dc.contributor.institutionauthorDogan Gungen, Belma
dc.contributor.institutionauthorTutpinar, Yildiray
dc.contributor.institutionauthorGuler, Mehtap
dc.relation.journalScandinavian Journal of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record